Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second-look versus second-nature

J S Berek

    Gynecologic Oncology
    |January 1, 1992
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety and dose modification for patients receiving niraparib.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Safety and dose modification for patients receiving niraparib.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Cytoreductive surgery for ovarian cancer: quality assessment.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Impact of the 2014 FDA Warnings Against Laparoscopic Power Morcellation.

    Journal of minimally invasive gynecology·2016
    Same author

    Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.

    British journal of cancer·2011
    Same author

    The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.

    British journal of cancer·2007
    Same journal

    Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

    Gynecologic oncology·2026
    Same journal

    Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

    Gynecologic oncology·2026
    Same journal

    Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

    Gynecologic oncology·2026
    Same journal

    PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

    Gynecologic oncology·2026
    Same journal

    A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

    Gynecologic oncology·2026
    Same journal

    Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

    Gynecologic oncology·2026
    See all related articles